{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:06:56Z","timestamp":1791216416243,"version":"4.1.0"},"reference-count":46,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T00:00:00Z","timestamp":1233100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Abnormal accumulation of fat in the liver (steatosis) is commonly observed in hepatitis C virus (HCV) infection, and the severity of steatosis has been well correlated with the degree of hepatic fibrosis. In patients with chronic HCV infection, steatosis may occur in conjunction with other metabolic risk factors such as insulin resistance and the metabolic syndrome. This was observed primarily in patients infected with non\u2010genotype 3 virus. Otherwise, in HCV\u2010infected patients, especially those infected with genotype 3a, reductions in total cholesterol as well as high\u2010density lipoprotein and low\u2010density lipoprotein cholesterol are observed compared with matched controls, and the normalization of these parameters appears to be an important correlate of the response to antiviral therapy. In that setting, the pathogenic mechanisms involved in HCV\u2010induced steatosis are mediated in large part by the HCV core protein, whose expression is associated with lipid droplet accumulation, changes in lipogenic gene expression and\/or the activity of lipogenic proteins, and effects on mitochondrial oxidative function. The importance of genes such as peroxisome proliferator\u2010activated receptor\u2010\u03b1 and the proteasome activator PA28\u2010\u03b3 in HCV\u2010mediated steatosis has been elucidated from studies in genetically altered mice, and the manipulation of these and other pathways may provide an avenue for therapeutic intervention.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2008.01950.x","type":"journal-article","created":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T02:05:03Z","timestamp":1233108303000},"page":"26-37","source":"Crossref","is-referenced-by-count":136,"title":["Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data"],"prefix":"10.1111","volume":"29","author":[{"given":"Francesco","family":"Negro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,28]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-860869"},{"key":"e_1_2_7_3_2","first-page":"1636","article-title":"Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C","volume":"130","author":"Leandro G","year":"2006","journal-title":"a meta-analysis of individual patient data"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000135372.10846.2a"},{"key":"e_1_2_7_5_2","first-page":"729","article-title":"Steatosis in chronic hepatitis C","volume":"36","author":"Monto A","year":"2002","journal-title":"relative contributions of obesity, diabetes mellitus, and alcohol"},{"key":"e_1_2_7_6_2","first-page":"117","article-title":"Steatosis in hepatitis C virus infection. Response to anti\u2010viral therapy","volume":"15","author":"Szanto P","year":"2006","journal-title":"J Gastrointestin Liver Dis"},{"key":"e_1_2_7_7_2","first-page":"329","article-title":"Metabolic aspects of hepatitis C viral infection","volume":"40","author":"Koike K","year":"2005","journal-title":"steatohepatitis resembling but distinct from NASH"},{"key":"e_1_2_7_8_2","first-page":"605","article-title":"Hepatitis C and insulin resistance","volume":"98","author":"Romero\u2010G\u00f3mez M.","year":"2006","journal-title":"steatosis, fibrosis and non-response"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890510037383"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33573"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/beem.2002.0225"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.6.1364"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.3.797"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.8.2169"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.050302"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308617100"},{"key":"e_1_2_7_17_2","first-page":"217","article-title":"Fatty liver and insulin resistance","volume":"119","author":"Schonfeld G","year":"2008","journal-title":"not always linked"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21763"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80166-X"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.12.034"},{"key":"e_1_2_7_21_2","first-page":"56","article-title":"Serum lipid pattern in chronic hepatitis C","volume":"13","author":"Siagris D","year":"2006","journal-title":"histological and virological correlations"},{"key":"e_1_2_7_22_2","first-page":"887","article-title":"Lipid metabolism in children with chronic hepatitis C, a preliminary report","volume":"53","author":"Wisniewska\u2010Ligier M","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.07056.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.04911.x"},{"key":"e_1_2_7_25_2","first-page":"428","article-title":"Hepatitis C virus induced hypobetalipoproteinemia","volume":"34","author":"Serfaty L","year":"2001","journal-title":"a possible mechanism for steatosis in chronic hepatitis C"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.202608199"},{"key":"e_1_2_7_27_2","first-page":"999","article-title":"Up\u2010regulation of fatty acid synthase promoter by hepatitis C virus core protein","volume":"46","author":"Jackel\u2010Cram C","year":"2007","journal-title":"genotype-3a core has a stronger effect than genotype-1b core"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-2788-1"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90031-7"},{"key":"e_1_2_7_30_2","first-page":"835","article-title":"The nuclear receptor superfamily","volume":"83","author":"Mangelsdorf DJ","year":"1995","journal-title":"the second decade"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.016"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M100258200"},{"key":"e_1_2_7_33_2","first-page":"683","article-title":"PPARalpha activation is essential for HCV core protein\u2010induced hepatic steatosis and hepatocellular carcinoma in mice","volume":"118","author":"Tanaka N","year":"2008","journal-title":"J Clin Invest"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00125-07"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.20.11041"},{"key":"e_1_2_7_36_2","first-page":"1125","article-title":"SREBPs","volume":"109","author":"Horton JD","year":"2002","journal-title":"activators of the complete program of cholesterol and fatty acid synthesis in the liver"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607312104"},{"key":"e_1_2_7_38_2","first-page":"185","article-title":"Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion","volume":"16","author":"Perlemuter G","year":"2002","journal-title":"a model of viral-related steatosis"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.02.035"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04591.x"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.30983"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M506412200"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7345com"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00321-06"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1086\/524846"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.108647"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22288"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2008.01950.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2008.01950.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T14:47:33Z","timestamp":1694443653000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2008.01950.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,28]]},"references-count":46,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1478-3231.2008.01950.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01950.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,28]]}}}